Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-12-21

Clinical Trial Update: Effect of Oral Glutamine on Muscle Mass and Function in Duchenne Muscular Dystrophy [Phase 2]

View source ↗

Summary

A completed Phase 2 clinical trial investigated whether oral glutamine can improve muscle mass and function in Duchenne muscular dystrophy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Glutamine (glutamine)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Muscular Dystrophy, Duchenne | Phase 2 | Status: COMPLETED